Cargando…
Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis
OBJECTIVES: Histone deacetylase (HDAC) 6 promotes inflammation. We investigated the anti-arthritic effects of CKD-506, a novel HDAC6 inhibitor, in vitro and in a murine model of arthritis as a novel treatment option for rheumatoid arthritis (RA). METHODS: HDAC6 was overexpressed in mouse peritoneal...
Autores principales: | Park, Jin Kyun, Jang, Yu Jin, Oh, Bo Ram, Shin, Jieun, Bae, Daekwon, Ha, Nina, Choi, Young il, Youn, Gi Soo, Park, Jinseu, Lee, Eun Young, Lee, Eun Bong, Song, Yeong Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382061/ https://www.ncbi.nlm.nih.gov/pubmed/32711562 http://dx.doi.org/10.1186/s13075-020-02258-0 |
Ejemplares similares
-
Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro
por: Oh, Bo Ram, et al.
Publicado: (2017) -
Inhibition of histone deacetylase 6 suppresses inflammatory responses and invasiveness of fibroblast-like-synoviocytes in inflammatory arthritis
por: Park, Jin Kyun, et al.
Publicado: (2021) -
CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis
por: Bae, Daekwon, et al.
Publicado: (2021) -
CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
por: Chang, Young, et al.
Publicado: (2020) -
The effects of PEP-1-FK506BP on dry eye disease in a rat model
por: Kim, Dae Won, et al.
Publicado: (2015)